128 related articles for article (PubMed ID: 12408659)
21. Malaria cure with sulphadoxine/pyrimethamine combination in 12 semi-immune adults from West-Central Africa with high rates of point mutations in Plasmodium falciparum dhfr and dhps genes.
Berzosa PJ; Puente S; Benito A
Parasitol Res; 2005 Oct; 97(4):287-9. PubMed ID: 16012864
[TBL] [Abstract][Full Text] [Related]
22. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
[TBL] [Abstract][Full Text] [Related]
23. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
[TBL] [Abstract][Full Text] [Related]
24. Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.
Djaman JA; Mazabraud A; Basco L
Ann Trop Med Parasitol; 2007 Mar; 101(2):103-12. PubMed ID: 17316496
[TBL] [Abstract][Full Text] [Related]
25. dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.
Alker AP; Kazadi WM; Kutelemeni AK; Bloland PB; Tshefu AK; Meshnick SR
Trop Med Int Health; 2008 Nov; 13(11):1384-91. PubMed ID: 19055622
[TBL] [Abstract][Full Text] [Related]
26. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes.
Jelinek T; Kilian AH; Kabagambe G; von Sonnenburg F
Am J Trop Med Hyg; 1999 Sep; 61(3):463-6. PubMed ID: 10497991
[TBL] [Abstract][Full Text] [Related]
27. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P
J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261
[TBL] [Abstract][Full Text] [Related]
28. Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali.
Diourté Y; Djimdé A; Doumbo OK; Sagara I; Coulibaly Y; Dicko A; Diallo M; Diakité M; Cortese JF; Plowe CV
Am J Trop Med Hyg; 1999 Mar; 60(3):475-8. PubMed ID: 10466980
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia.
Nagesha HS; Din-Syafruddin ; Casey GJ; Susanti AI; Fryauff DJ; Reeder JC; Cowman AF
Trans R Soc Trop Med Hyg; 2001; 95(1):43-9. PubMed ID: 11280065
[TBL] [Abstract][Full Text] [Related]
30. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.
Kyabayinze D; Cattamanchi A; Kamya MR; Rosenthal PJ; Dorsey G
Am J Trop Med Hyg; 2003 Sep; 69(3):247-52. PubMed ID: 14628939
[TBL] [Abstract][Full Text] [Related]
31. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
Alifrangis M; Enosse S; Khalil IF; Tarimo DS; Lemnge MM; Thompson R; Bygbjerg IC; Rønn AM
Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875
[TBL] [Abstract][Full Text] [Related]
32. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
Kublin JG; Dzinjalamala FK; Kamwendo DD; Malkin EM; Cortese JF; Martino LM; Mukadam RA; Rogerson SJ; Lescano AG; Molyneux ME; Winstanley PA; Chimpeni P; Taylor TE; Plowe CV
J Infect Dis; 2002 Feb; 185(3):380-8. PubMed ID: 11807721
[TBL] [Abstract][Full Text] [Related]
33. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria.
Méndez F; Muñoz A; Carrasquilla G; Jurado D; Arévalo-Herrera M; Cortese JF; Plowe CV
Am J Epidemiol; 2002 Aug; 156(3):230-8. PubMed ID: 12142257
[TBL] [Abstract][Full Text] [Related]
34. [Sulfadoxine-pyrimethamine resistance in Maputo, Mozambique: presence of mutations in the dhfr and dhps genes of Plasmodium falciparum].
Fernandes NE; Cravo P; do Rosário VE
Rev Soc Bras Med Trop; 2007; 40(4):447-50. PubMed ID: 17876469
[TBL] [Abstract][Full Text] [Related]
35. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
[TBL] [Abstract][Full Text] [Related]
36. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.
Wang P; Read M; Sims PF; Hyde JE
Mol Microbiol; 1997 Mar; 23(5):979-86. PubMed ID: 9076734
[TBL] [Abstract][Full Text] [Related]
37. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
[TBL] [Abstract][Full Text] [Related]
38. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
Mita T; Kaneko A; Hwaihwanje I; Tsukahara T; Takahashi N; Osawa H; Tanabe K; Kobayakawa T; Björkman A
Infect Genet Evol; 2006 Nov; 6(6):447-52. PubMed ID: 16600696
[TBL] [Abstract][Full Text] [Related]
39. Short communication: point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Colombia.
Schmider N; Peyerl-Hoffmann G; Restrepo M; Jelinek T
Trop Med Int Health; 2003 Feb; 8(2):129-32. PubMed ID: 12581437
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance.
Jelinek T; Rønn AM; Curtis J; Duraisingh MT; Lemnge MM; Mhina J; Bygbjerg IC; Warhurst DC
Trop Med Int Health; 1997 Nov; 2(11):1075-9. PubMed ID: 9391510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]